Stock Information
Regeneron Pharmaceuticals Inc (REGN)
Ticker Symbol: REGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $76,137,138,835.00 mil
Piotroski score: 6
PE Ratio: 18.021
EPS (TTM): 41.7842
Revenue (TTM): $132.91 M
Dividend Yield: 0.4484248%
ROE: 15.31%
Latest News
-
Can Amgen Sustain Its Rally In 2026
Fri, Dec 26, 2025 1:03 PM
-
Does Regeneron Still Offer Value After Strong Five Year Share Price Gains?
Tue, Dec 23, 2025 10:12 PM
-
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Tue, Dec 23, 2025 6:00 AM
-
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
Tue, Dec 23, 2025 6:00 AM
-
Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
Mon, Dec 22, 2025 9:05 PM
-
Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains?
Mon, Dec 22, 2025 12:11 PM
-
2025 Performance Review And Future Strategy
Mon, Dec 22, 2025 8:30 AM
Key Financials
Financial data not available
